Global Prostate Cancer Drugs Market Insights and Forecast to 2028

Global Prostate Cancer Drugs Market Insights and Forecast to 2028

Table of Contents
1 Study Coverage
1.1 Prostate Cancer Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Prostate Cancer Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Hormonal Therapy
1.2.3 Chemotherapy
1.2.4 Immunotherapy
1.2.5 Targeted Therapy
1.3 Market by Application
1.3.1 Global Prostate Cancer Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Clinics
1.3.3 Hospitals
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Prostate Cancer Drugs Sales Estimates and Forecasts 2017-2028
2.2 Global Prostate Cancer Drugs Revenue Estimates and Forecasts 2017-2028
2.3 Global Prostate Cancer Drugs Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Prostate Cancer Drugs Sales by Region
2.4.1 Global Prostate Cancer Drugs Sales by Region (2017-2022)
2.4.2 Global Sales Prostate Cancer Drugs by Region (2023-2028)
2.5 Global Prostate Cancer Drugs Revenue by Region
2.5.1 Global Prostate Cancer Drugs Revenue by Region (2017-2022)
2.5.2 Global Prostate Cancer Drugs Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Prostate Cancer Drugs Sales by Manufacturers
3.1.1 Global Top Prostate Cancer Drugs Manufacturers by Sales (2017-2022)
3.1.2 Global Prostate Cancer Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Prostate Cancer Drugs in 2021
3.2 Global Prostate Cancer Drugs Revenue by Manufacturers
3.2.1 Global Prostate Cancer Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Global Prostate Cancer Drugs Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Prostate Cancer Drugs Revenue in 2021
3.3 Global Prostate Cancer Drugs Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Prostate Cancer Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Prostate Cancer Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Prostate Cancer Drugs Sales by Type
4.1.1 Global Prostate Cancer Drugs Historical Sales by Type (2017-2022)
4.1.2 Global Prostate Cancer Drugs Forecasted Sales by Type (2023-2028)
4.1.3 Global Prostate Cancer Drugs Sales Market Share by Type (2017-2028)
4.2 Global Prostate Cancer Drugs Revenue by Type
4.2.1 Global Prostate Cancer Drugs Historical Revenue by Type (2017-2022)
4.2.2 Global Prostate Cancer Drugs Forecasted Revenue by Type (2023-2028)
4.2.3 Global Prostate Cancer Drugs Revenue Market Share by Type (2017-2028)
4.3 Global Prostate Cancer Drugs Price by Type
4.3.1 Global Prostate Cancer Drugs Price by Type (2017-2022)
4.3.2 Global Prostate Cancer Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Prostate Cancer Drugs Sales by Application
5.1.1 Global Prostate Cancer Drugs Historical Sales by Application (2017-2022)
5.1.2 Global Prostate Cancer Drugs Forecasted Sales by Application (2023-2028)
5.1.3 Global Prostate Cancer Drugs Sales Market Share by Application (2017-2028)
5.2 Global Prostate Cancer Drugs Revenue by Application
5.2.1 Global Prostate Cancer Drugs Historical Revenue by Application (2017-2022)
5.2.2 Global Prostate Cancer Drugs Forecasted Revenue by Application (2023-2028)
5.2.3 Global Prostate Cancer Drugs Revenue Market Share by Application (2017-2028)
5.3 Global Prostate Cancer Drugs Price by Application
5.3.1 Global Prostate Cancer Drugs Price by Application (2017-2022)
5.3.2 Global Prostate Cancer Drugs Price Forecast by Application (2023-2028)
6 North America
6.1 North America Prostate Cancer Drugs Market Size by Type
6.1.1 North America Prostate Cancer Drugs Sales by Type (2017-2028)
6.1.2 North America Prostate Cancer Drugs Revenue by Type (2017-2028)
6.2 North America Prostate Cancer Drugs Market Size by Application
6.2.1 North America Prostate Cancer Drugs Sales by Application (2017-2028)
6.2.2 North America Prostate Cancer Drugs Revenue by Application (2017-2028)
6.3 North America Prostate Cancer Drugs Market Size by Country
6.3.1 North America Prostate Cancer Drugs Sales by Country (2017-2028)
6.3.2 North America Prostate Cancer Drugs Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Prostate Cancer Drugs Market Size by Type
7.1.1 Europe Prostate Cancer Drugs Sales by Type (2017-2028)
7.1.2 Europe Prostate Cancer Drugs Revenue by Type (2017-2028)
7.2 Europe Prostate Cancer Drugs Market Size by Application
7.2.1 Europe Prostate Cancer Drugs Sales by Application (2017-2028)
7.2.2 Europe Prostate Cancer Drugs Revenue by Application (2017-2028)
7.3 Europe Prostate Cancer Drugs Market Size by Country
7.3.1 Europe Prostate Cancer Drugs Sales by Country (2017-2028)
7.3.2 Europe Prostate Cancer Drugs Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Prostate Cancer Drugs Market Size by Type
8.1.1 Asia Pacific Prostate Cancer Drugs Sales by Type (2017-2028)
8.1.2 Asia Pacific Prostate Cancer Drugs Revenue by Type (2017-2028)
8.2 Asia Pacific Prostate Cancer Drugs Market Size by Application
8.2.1 Asia Pacific Prostate Cancer Drugs Sales by Application (2017-2028)
8.2.2 Asia Pacific Prostate Cancer Drugs Revenue by Application (2017-2028)
8.3 Asia Pacific Prostate Cancer Drugs Market Size by Region
8.3.1 Asia Pacific Prostate Cancer Drugs Sales by Region (2017-2028)
8.3.2 Asia Pacific Prostate Cancer Drugs Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Prostate Cancer Drugs Market Size by Type
9.1.1 Latin America Prostate Cancer Drugs Sales by Type (2017-2028)
9.1.2 Latin America Prostate Cancer Drugs Revenue by Type (2017-2028)
9.2 Latin America Prostate Cancer Drugs Market Size by Application
9.2.1 Latin America Prostate Cancer Drugs Sales by Application (2017-2028)
9.2.2 Latin America Prostate Cancer Drugs Revenue by Application (2017-2028)
9.3 Latin America Prostate Cancer Drugs Market Size by Country
9.3.1 Latin America Prostate Cancer Drugs Sales by Country (2017-2028)
9.3.2 Latin America Prostate Cancer Drugs Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Prostate Cancer Drugs Market Size by Type
10.1.1 Middle East and Africa Prostate Cancer Drugs Sales by Type (2017-2028)
10.1.2 Middle East and Africa Prostate Cancer Drugs Revenue by Type (2017-2028)
10.2 Middle East and Africa Prostate Cancer Drugs Market Size by Application
10.2.1 Middle East and Africa Prostate Cancer Drugs Sales by Application (2017-2028)
10.2.2 Middle East and Africa Prostate Cancer Drugs Revenue by Application (2017-2028)
10.3 Middle East and Africa Prostate Cancer Drugs Market Size by Country
10.3.1 Middle East and Africa Prostate Cancer Drugs Sales by Country (2017-2028)
10.3.2 Middle East and Africa Prostate Cancer Drugs Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 AbbVie
11.1.1 AbbVie Corporation Information
11.1.2 AbbVie Overview
11.1.3 AbbVie Prostate Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 AbbVie Prostate Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 AbbVie Recent Developments
11.2 Astellas Pharma
11.2.1 Astellas Pharma Corporation Information
11.2.2 Astellas Pharma Overview
11.2.3 Astellas Pharma Prostate Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Astellas Pharma Prostate Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Astellas Pharma Recent Developments
11.3 Astra Zeneca
11.3.1 Astra Zeneca Corporation Information
11.3.2 Astra Zeneca Overview
11.3.3 Astra Zeneca Prostate Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Astra Zeneca Prostate Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Astra Zeneca Recent Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Corporation Information
11.4.2 Johnson & Johnson Overview
11.4.3 Johnson & Johnson Prostate Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Johnson & Johnson Prostate Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Johnson & Johnson Recent Developments
11.5 Sanofi
11.5.1 Sanofi Corporation Information
11.5.2 Sanofi Overview
11.5.3 Sanofi Prostate Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Sanofi Prostate Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Sanofi Recent Developments
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Corporation Information
11.6.2 GlaxoSmithKline Overview
11.6.3 GlaxoSmithKline Prostate Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 GlaxoSmithKline Prostate Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 GlaxoSmithKline Recent Developments
11.7 Merck Group
11.7.1 Merck Group Corporation Information
11.7.2 Merck Group Overview
11.7.3 Merck Group Prostate Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Merck Group Prostate Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Merck Group Recent Developments
11.8 Novartis
11.8.1 Novartis Corporation Information
11.8.2 Novartis Overview
11.8.3 Novartis Prostate Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Novartis Prostate Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Novartis Recent Developments
11.9 Amgen
11.9.1 Amgen Corporation Information
11.9.2 Amgen Overview
11.9.3 Amgen Prostate Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Amgen Prostate Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Amgen Recent Developments
11.10 Bayer HealthCare
11.10.1 Bayer HealthCare Corporation Information
11.10.2 Bayer HealthCare Overview
11.10.3 Bayer HealthCare Prostate Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Bayer HealthCare Prostate Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Bayer HealthCare Recent Developments
11.11 Ferring Pharmaceutical
11.11.1 Ferring Pharmaceutical Corporation Information
11.11.2 Ferring Pharmaceutical Overview
11.11.3 Ferring Pharmaceutical Prostate Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Ferring Pharmaceutical Prostate Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Ferring Pharmaceutical Recent Developments
11.12 Janssen Pharmaceuticals
11.12.1 Janssen Pharmaceuticals Corporation Information
11.12.2 Janssen Pharmaceuticals Overview
11.12.3 Janssen Pharmaceuticals Prostate Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Janssen Pharmaceuticals Prostate Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Janssen Pharmaceuticals Recent Developments
11.13 Endo Pharmaceuticals
11.13.1 Endo Pharmaceuticals Corporation Information
11.13.2 Endo Pharmaceuticals Overview
11.13.3 Endo Pharmaceuticals Prostate Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Endo Pharmaceuticals Prostate Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Endo Pharmaceuticals Recent Developments
11.14 BMS
11.14.1 BMS Corporation Information
11.14.2 BMS Overview
11.14.3 BMS Prostate Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 BMS Prostate Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 BMS Recent Developments
11.15 Takeda Pharmaceuticals
11.15.1 Takeda Pharmaceuticals Corporation Information
11.15.2 Takeda Pharmaceuticals Overview
11.15.3 Takeda Pharmaceuticals Prostate Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Takeda Pharmaceuticals Prostate Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Takeda Pharmaceuticals Recent Developments
11.16 Northwest Biotherapeutics
11.16.1 Northwest Biotherapeutics Corporation Information
11.16.2 Northwest Biotherapeutics Overview
11.16.3 Northwest Biotherapeutics Prostate Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Northwest Biotherapeutics Prostate Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Northwest Biotherapeutics Recent Developments
11.17 Teva Pharmaceutical
11.17.1 Teva Pharmaceutical Corporation Information
11.17.2 Teva Pharmaceutical Overview
11.17.3 Teva Pharmaceutical Prostate Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 Teva Pharmaceutical Prostate Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Teva Pharmaceutical Recent Developments
11.18 Boehringer Ingelheim
11.18.1 Boehringer Ingelheim Corporation Information
11.18.2 Boehringer Ingelheim Overview
11.18.3 Boehringer Ingelheim Prostate Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.18.4 Boehringer Ingelheim Prostate Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Boehringer Ingelheim Recent Developments
11.19 Foresee Pharmaceuticals
11.19.1 Foresee Pharmaceuticals Corporation Information
11.19.2 Foresee Pharmaceuticals Overview
11.19.3 Foresee Pharmaceuticals Prostate Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.19.4 Foresee Pharmaceuticals Prostate Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 Foresee Pharmaceuticals Recent Developments
11.20 Tokai Pharmaceuticals
11.20.1 Tokai Pharmaceuticals Corporation Information
11.20.2 Tokai Pharmaceuticals Overview
11.20.3 Tokai Pharmaceuticals Prostate Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.20.4 Tokai Pharmaceuticals Prostate Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.20.5 Tokai Pharmaceuticals Recent Developments
11.21 Spectrum Pharmaceuticals
11.21.1 Spectrum Pharmaceuticals Corporation Information
11.21.2 Spectrum Pharmaceuticals Overview
11.21.3 Spectrum Pharmaceuticals Prostate Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.21.4 Spectrum Pharmaceuticals Prostate Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.21.5 Spectrum Pharmaceuticals Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Prostate Cancer Drugs Industry Chain Analysis
12.2 Prostate Cancer Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Prostate Cancer Drugs Production Mode & Process
12.4 Prostate Cancer Drugs Sales and Marketing
12.4.1 Prostate Cancer Drugs Sales Channels
12.4.2 Prostate Cancer Drugs Distributors
12.5 Prostate Cancer Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Prostate Cancer Drugs Industry Trends
13.2 Prostate Cancer Drugs Market Drivers
13.3 Prostate Cancer Drugs Market Challenges
13.4 Prostate Cancer Drugs Market Restraints
14 Key Findings in The Global Prostate Cancer Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Prostate Cancer Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Hormonal Therapy
Table 3. Major Manufacturers of Chemotherapy
Table 4. Major Manufacturers of Immunotherapy
Table 5. Major Manufacturers of Targeted Therapy
Table 6. Global Prostate Cancer Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Prostate Cancer Drugs Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Prostate Cancer Drugs Sales by Region (2017-2022) & (K MT)
Table 9. Global Prostate Cancer Drugs Sales Market Share by Region (2017-2022)
Table 10. Global Prostate Cancer Drugs Sales by Region (2023-2028) & (K MT)
Table 11. Global Prostate Cancer Drugs Sales Market Share by Region (2023-2028)
Table 12. Global Prostate Cancer Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 13. Global Prostate Cancer Drugs Revenue Market Share by Region (2017-2022)
Table 14. Global Prostate Cancer Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 15. Global Prostate Cancer Drugs Revenue Market Share by Region (2023-2028)
Table 16. Global Prostate Cancer Drugs Sales by Manufacturers (2017-2022) & (K MT)
Table 17. Global Prostate Cancer Drugs Sales Share by Manufacturers (2017-2022)
Table 18. Global Prostate Cancer Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 19. Global Prostate Cancer Drugs Revenue Share by Manufacturers (2017-2022)
Table 20. Prostate Cancer Drugs Price by Manufacturers (2017-2022) &(USD/MT)
Table 21. Global Prostate Cancer Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Prostate Cancer Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Drugs as of 2021)
Table 23. Prostate Cancer Drugs Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Prostate Cancer Drugs Product Offered
Table 25. Date of Manufacturers Enter into Prostate Cancer Drugs Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Prostate Cancer Drugs Sales by Type (2017-2022) & (K MT)
Table 28. Global Prostate Cancer Drugs Sales by Type (2023-2028) & (K MT)
Table 29. Global Prostate Cancer Drugs Sales Share by Type (2017-2022)
Table 30. Global Prostate Cancer Drugs Sales Share by Type (2023-2028)
Table 31. Global Prostate Cancer Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 32. Global Prostate Cancer Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 33. Global Prostate Cancer Drugs Revenue Share by Type (2017-2022)
Table 34. Global Prostate Cancer Drugs Revenue Share by Type (2023-2028)
Table 35. Prostate Cancer Drugs Price by Type (2017-2022) & (USD/MT)
Table 36. Global Prostate Cancer Drugs Price Forecast by Type (2023-2028) & (USD/MT)
Table 37. Global Prostate Cancer Drugs Sales by Application (2017-2022) & (K MT)
Table 38. Global Prostate Cancer Drugs Sales by Application (2023-2028) & (K MT)
Table 39. Global Prostate Cancer Drugs Sales Share by Application (2017-2022)
Table 40. Global Prostate Cancer Drugs Sales Share by Application (2023-2028)
Table 41. Global Prostate Cancer Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 42. Global Prostate Cancer Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 43. Global Prostate Cancer Drugs Revenue Share by Application (2017-2022)
Table 44. Global Prostate Cancer Drugs Revenue Share by Application (2023-2028)
Table 45. Prostate Cancer Drugs Price by Application (2017-2022) & (USD/MT)
Table 46. Global Prostate Cancer Drugs Price Forecast by Application (2023-2028) & (USD/MT)
Table 47. North America Prostate Cancer Drugs Sales by Type (2017-2022) & (K MT)
Table 48. North America Prostate Cancer Drugs Sales by Type (2023-2028) & (K MT)
Table 49. North America Prostate Cancer Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 50. North America Prostate Cancer Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 51. North America Prostate Cancer Drugs Sales by Application (2017-2022) & (K MT)
Table 52. North America Prostate Cancer Drugs Sales by Application (2023-2028) & (K MT)
Table 53. North America Prostate Cancer Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 54. North America Prostate Cancer Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 55. North America Prostate Cancer Drugs Sales by Country (2017-2022) & (K MT)
Table 56. North America Prostate Cancer Drugs Sales by Country (2023-2028) & (K MT)
Table 57. North America Prostate Cancer Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 58. North America Prostate Cancer Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 59. Europe Prostate Cancer Drugs Sales by Type (2017-2022) & (K MT)
Table 60. Europe Prostate Cancer Drugs Sales by Type (2023-2028) & (K MT)
Table 61. Europe Prostate Cancer Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 62. Europe Prostate Cancer Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 63. Europe Prostate Cancer Drugs Sales by Application (2017-2022) & (K MT)
Table 64. Europe Prostate Cancer Drugs Sales by Application (2023-2028) & (K MT)
Table 65. Europe Prostate Cancer Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 66. Europe Prostate Cancer Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 67. Europe Prostate Cancer Drugs Sales by Country (2017-2022) & (K MT)
Table 68. Europe Prostate Cancer Drugs Sales by Country (2023-2028) & (K MT)
Table 69. Europe Prostate Cancer Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 70. Europe Prostate Cancer Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 71. Asia Pacific Prostate Cancer Drugs Sales by Type (2017-2022) & (K MT)
Table 72. Asia Pacific Prostate Cancer Drugs Sales by Type (2023-2028) & (K MT)
Table 73. Asia Pacific Prostate Cancer Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 74. Asia Pacific Prostate Cancer Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 75. Asia Pacific Prostate Cancer Drugs Sales by Application (2017-2022) & (K MT)
Table 76. Asia Pacific Prostate Cancer Drugs Sales by Application (2023-2028) & (K MT)
Table 77. Asia Pacific Prostate Cancer Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 78. Asia Pacific Prostate Cancer Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 79. Asia Pacific Prostate Cancer Drugs Sales by Region (2017-2022) & (K MT)
Table 80. Asia Pacific Prostate Cancer Drugs Sales by Region (2023-2028) & (K MT)
Table 81. Asia Pacific Prostate Cancer Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 82. Asia Pacific Prostate Cancer Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 83. Latin America Prostate Cancer Drugs Sales by Type (2017-2022) & (K MT)
Table 84. Latin America Prostate Cancer Drugs Sales by Type (2023-2028) & (K MT)
Table 85. Latin America Prostate Cancer Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 86. Latin America Prostate Cancer Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 87. Latin America Prostate Cancer Drugs Sales by Application (2017-2022) & (K MT)
Table 88. Latin America Prostate Cancer Drugs Sales by Application (2023-2028) & (K MT)
Table 89. Latin America Prostate Cancer Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 90. Latin America Prostate Cancer Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 91. Latin America Prostate Cancer Drugs Sales by Country (2017-2022) & (K MT)
Table 92. Latin America Prostate Cancer Drugs Sales by Country (2023-2028) & (K MT)
Table 93. Latin America Prostate Cancer Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 94. Latin America Prostate Cancer Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 95. Middle East and Africa Prostate Cancer Drugs Sales by Type (2017-2022) & (K MT)
Table 96. Middle East and Africa Prostate Cancer Drugs Sales by Type (2023-2028) & (K MT)
Table 97. Middle East and Africa Prostate Cancer Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 98. Middle East and Africa Prostate Cancer Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 99. Middle East and Africa Prostate Cancer Drugs Sales by Application (2017-2022) & (K MT)
Table 100. Middle East and Africa Prostate Cancer Drugs Sales by Application (2023-2028) & (K MT)
Table 101. Middle East and Africa Prostate Cancer Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 102. Middle East and Africa Prostate Cancer Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 103. Middle East and Africa Prostate Cancer Drugs Sales by Country (2017-2022) & (K MT)
Table 104. Middle East and Africa Prostate Cancer Drugs Sales by Country (2023-2028) & (K MT)
Table 105. Middle East and Africa Prostate Cancer Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 106. Middle East and Africa Prostate Cancer Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 107. AbbVie Corporation Information
Table 108. AbbVie Description and Major Businesses
Table 109. AbbVie Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 110. AbbVie Prostate Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. AbbVie Recent Developments
Table 112. Astellas Pharma Corporation Information
Table 113. Astellas Pharma Description and Major Businesses
Table 114. Astellas Pharma Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 115. Astellas Pharma Prostate Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Astellas Pharma Recent Developments
Table 117. Astra Zeneca Corporation Information
Table 118. Astra Zeneca Description and Major Businesses
Table 119. Astra Zeneca Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 120. Astra Zeneca Prostate Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Astra Zeneca Recent Developments
Table 122. Johnson & Johnson Corporation Information
Table 123. Johnson & Johnson Description and Major Businesses
Table 124. Johnson & Johnson Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 125. Johnson & Johnson Prostate Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Johnson & Johnson Recent Developments
Table 127. Sanofi Corporation Information
Table 128. Sanofi Description and Major Businesses
Table 129. Sanofi Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 130. Sanofi Prostate Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Sanofi Recent Developments
Table 132. GlaxoSmithKline Corporation Information
Table 133. GlaxoSmithKline Description and Major Businesses
Table 134. GlaxoSmithKline Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 135. GlaxoSmithKline Prostate Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. GlaxoSmithKline Recent Developments
Table 137. Merck Group Corporation Information
Table 138. Merck Group Description and Major Businesses
Table 139. Merck Group Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 140. Merck Group Prostate Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Merck Group Recent Developments
Table 142. Novartis Corporation Information
Table 143. Novartis Description and Major Businesses
Table 144. Novartis Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 145. Novartis Prostate Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Novartis Recent Developments
Table 147. Amgen Corporation Information
Table 148. Amgen Description and Major Businesses
Table 149. Amgen Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 150. Amgen Prostate Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Amgen Recent Developments
Table 152. Bayer HealthCare Corporation Information
Table 153. Bayer HealthCare Description and Major Businesses
Table 154. Bayer HealthCare Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 155. Bayer HealthCare Prostate Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Bayer HealthCare Recent Developments
Table 157. Ferring Pharmaceutical Corporation Information
Table 158. Ferring Pharmaceutical Description and Major Businesses
Table 159. Ferring Pharmaceutical Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 160. Ferring Pharmaceutical Prostate Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Ferring Pharmaceutical Recent Developments
Table 162. Janssen Pharmaceuticals Corporation Information
Table 163. Janssen Pharmaceuticals Description and Major Businesses
Table 164. Janssen Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 165. Janssen Pharmaceuticals Prostate Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. Janssen Pharmaceuticals Recent Developments
Table 167. Endo Pharmaceuticals Corporation Information
Table 168. Endo Pharmaceuticals Description and Major Businesses
Table 169. Endo Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 170. Endo Pharmaceuticals Prostate Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global 5-Fluorouracil Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 76

The global 5-Fluorouracil market was valued at US$ 283 million in 2023 and is anticipated to reach US$ 487.9 million by 2030, witnessing a CAGR of 4.3% during The forecast period 2024-2030. North American market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by ......

Global Carboplatin Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global Carboplatin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % d......

Global Neutropenia Drugs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 96

The global Neutropenia Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated to increa......

Global Small Molecule Cancer Drug Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Small Molecule Cancer Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated ......

Global Capecitabine Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 80

Capecitabine is an orally-administered chemotherapeutic agent used in The treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in The tumor, where it inhibits DNA synthesis and slows growth of tumor tissue. Common side effects include abdominal pain, vomiting, diarrhea, weakness, and rashes. Other severe side effects include blood clotting problems, allergic reactions, heart problems, and low blo......

Global Oxaliplatin Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 104

Oxaliplatin is a platinum-based anticancer drug with colorless or nearly colorless transparent liquid. It is often used for metastatic colorectal cancer treatment or adjuvant therapy The third stage colon cancer after resecting primary tumor completely. In this report, only The finished drug is covered, exclude API. The global Oxaliplatin market was valued at US$ 897.5 million in 2023 and is anticipated to reach US$ 1641.5 million by 2030, witnessing a CAGR of 8.9% duri......

Global Cancer Treatment Drugs Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 158

According to our LPI (LP Information) latest study, the global Cancer Treatment Drugs market size was valued at US$ 174990 million in 2023. With growing demand in downstream market, the Cancer Treatment Drugs is forecast to a readjusted size of US$ 322540 million by 2030 with a CAGR of 9.1% during review period. The research report highlights the growth potential of the global Cancer Treatment Drugs market. Cancer Treatment Drugs are expected to show stable growth in the future market. H......

Global Capecitabine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 93

According to our LPI (LP Information) latest study, the global Capecitabine market size was valued at US$ 1003.9 million in 2023. With growing demand in downstream market, the Capecitabine is forecast to a readjusted size of US$ 975.1 million by 2030 with a CAGR of -0.4% during review period. The research report highlights the growth potential of the global Capecitabine market. Capecitabine are expected to show stable growth in the future market. However, product differentiation, reducin......

Global Methotrexate Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95

According to our LPI (LP Information) latest study, the global Methotrexate market size was valued at US$ 506 million in 2023. With growing demand in downstream market, the Methotrexate is forecast to a readjusted size of US$ 613.9 million by 2030 with a CAGR of 2.8% during review period. The research report highlights the growth potential of the global Methotrexate market. Methotrexate are expected to show stable growth in the future market. However, product differentiation, reducing co......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs